Nosocomially acquired urinary tract infections in urology departments: Why an international prevalence study is needed in urology

International Journal of Antimicrobial Agents

Volumn 23, Issue SUPPL. 1, 2004, Pages 30-34

  Johansen, Truls E Bjerklund ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Nosocomial urinary tract infections; Prevalence study; Urology

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BIOLOGICAL MONITORING; CATHETER INFECTION; CONFERENCE PAPER; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HOSPITAL CARE; HOSPITAL DEPARTMENT; HOSPITAL INFECTION; HUMAN; INCIDENCE; INDWELLING CATHETER; INFECTION RISK; INSTITUTIONAL CARE; LEGAL ASPECT; MEDICAL PRACTICE; MEDICAL SOCIETY; PATHOGENESIS; PERIOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; SURGICAL TECHNIQUE; URINARY TRACT INFECTION; UROLOGY;

EID: 1642268220     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.09.003     Document Type: Conference Paper

References (15)

1. Garner J.C., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections. Am. J. Infect. Contr. 16:1988;128-140.
2. Naber K, Pechere JC, Kumazawa J, Khoury S, Gerberding JL, Schaeffer AJ, editors. Nosocomial and Health Care Associated Infections in Urology. Plymouth: Health Publication Ltd.; 2001.
3. Vincent J.-L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.-H.et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA. 274:1995;639-644.
4. Gastmeier P., Kampf G., Wischnewski N., Hauer T., Schulgen G., Schumacher M.et al. Prevalence of nosocomial infections in representative German hospitals. J. Hosp. Infect. 38:1998;37-49.
5. Bouza E., San Juan R., Munoz P., Voss A., Kluytmans J. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). Clin. Microbiol. Infect. 7:2001;532-542.
6. Naber K.G., Bergman B., Bishop M.C., Bjerklund Johansen T.E., Butto H., Lobel B.et al. EAU Guidelines for the management of urinary and male genital tract infections. Eur. Urol. 40:2001;576-588.
7. Grabe M. Controversies in antibiotic prophylaxis in urology. Int J Antimicrob Agents. 23(Suppl. 1):2004;17-23.
8. Berry A., Barratt A. Prophylactic antibiotic use in transurethral prostatic resection. A meta-analysis. J. Urol. 167:2002;571-577.
9. Gerberding J, Schaeffer A, Bjerklund Johansen TE, Chechile G, Grise P, Naito S, et al. Outcome and performance measurements. In: Naber K, Pechere JC, Kumazawa J, Khoury S, Gerberding JL, Schaeffer AJ, editors. Nosocomial and Health Care Associated Infections in Urology. Plymouth: Health Publication Ltd. ; 2001, Chapter VIII. p. 195-201.
10. Elo JH. The history of urinary infections. De Historia Urologia Europaeae, vol. 8. EAU Historical Committee, EAU, 2001.
11. Kalmeter G. The ECO*SENS project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens - interim report. J. Antimicrob. Chemother. 46:2000;15-22.
12. Mazulli T. Resistance trends in urinary tract pathogens and impact on management. J. Urol. 168:2002;1720-1722.
13. Wagenlehner F.M.E., Krcmery S., Held C., Klare I., Witte W., Bauernfeind A.et al. Epidemiological analysis of the spread of pathogens from a urological ward using genotypic, phenotypic and clinical parameters. Int. J. Antimicrob. Agents. 19:2002;583-591.
14. Palou Redorta J. Surveillance of NAUTI. How we do it? European Society for Infections in Urology/European Association in Urology XVIII Congress, Madrid, 2003 [oral presentation].
15. Bjerklund Johansen T.E. Join the Pan-European Study on nosocomial infections in urology. Eur. Urol. Today. 14:2003;9.